Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
This study has been completed.
Study NCT00071461   Information provided by Actelion
First Received: October 23, 2003   Last Updated: July 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Pulmonary Fibrosis
Additional conditions recognized in this trial
Fibrosis
Pulmonary Fibrosis
More general conditions related to this trial
Lung Diseases
Lung Diseases, Interstitial
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
bosentan
Placebo
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Actelion


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services